Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  EntreMed Inc    

SummaryNewsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Develops pharmaceutical drugs for treating cancer and inflammatory diseases

CASI Pharmaceuticals, Inc. is a biopharmaceutical company focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs with commercial focus on the China market.

The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong and Macau.

The drugs are Captisol-Enabled, ZEVALIN and MARQIBO.

CASI Pharmaceuticals was founded in 1991 and is headquartered in Rockville, MD.
Managers
NameAgeSinceTitle
Ken Keyong Ren MD, PhD582012Chief Executive Officer & Director
Wei-Wu He PhD, MBA522012Executive Chairman
Cynthia Wong Hu472006COO, Secretary, Vice President & General Counsel
Sara B. Capitelli, CPA502011Chief Accounting Officer & Vice President-Finance
Zuie Chin Huang, MBA522013Independent Director
Yue Wu PhD, MBA532013Independent Director
Franklin Cary Salisbury, Jr.612014Independent Director
Rajesh C. Shrotriya, MD732014Independent Director
Quan Zhou, PhD592016Director
James E. Goldschmidt, PhD-2016Vice President-Business Development
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 60,276,119 29,124,243 48.3% 79,545 0.1% 48.3%
Shareholders
NameEquities%
Spectrum Pharmaceuticals, Inc. 10,028,579 16.7%
He Xie Ai Qi Investment Management Beijing Co. Ltd. 8,498,765 14.1%
IDG Capital Partners Co., Ltd. 5,452,385 9.06%
Zhejiang Kanglaite Group Co. Ltd. 4,938,269 8.20%
Emerging Technology Partners LLC 2,312,677 3.84%
Wellington Shields Capital Management LLC 728,447 1.21%
Wellington Shields & Co. LLC 505,474 0.84%
European & Global Advisers LLP 350,000 0.58%
The Vanguard Group, Inc. 346,177 0.58%
BlackRock Fund Advisors 265,108 0.44%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Biotechnology & Medical Research - NEC
Advertisement
Sector Biotechnology & Medical Research - NEC
1st jan.Capitalization (M$)
ENTREMED INC60
INCYTE CORPORATION38.04%27 518
QUINTILES IMS HOLDINGS..11.37%18 872
LONZA GROUP AG25.78%15 703
CELLTRION, INC.--.--%10 293
SEATTLE GENETICS, INC.25.11%9 358
ALKERMES PLC4.25%8 839
QIAGEN NV13.07%7 594
ALNYLAM PHARMACEUTICAL..85.63%6 020
IONIS PHARMACEUTICALS ..-3.09%5 750
UNITED THERAPEUTICS CO..-17.49%5 366
ICON PLC21.98%4 933
PRA HEALTH SCIENCES IN..31.30%4 521
CHARLES RIVER LABORATO..21.54%4 411
GALAPAGOS23.09%4 250
BIO-TECHNE CORP8.33%4 159
PAREXEL INTERNATIONAL ..22.05%4 072
EXACT SCIENCES CORPORA..149.40%3 705
NEKTAR THERAPEUTICS69.44%3 226
ACADIA PHARMACEUTICALS..-9.78%3 176
BB BIOTECH AG0.91%3 162
Sector Biotechnology & Medical Research - NEC
EntreMed Inc : Connections
The UNLV Foundation
Emerging Technology Partners LLC
MithraGen, Inc.
Superdata Software Holdings Ltd.
Wuhan Kindstar Diagnostics Co., Ltd.
Beijing Genetron Biotechnology Co. Ltd.
Amnis Corp.
Human Longevity, Inc.
Intradigm Corp.
IDG Technology Venture Investment IV LLC
ImmunoVentis, Inc.
OriGene Technologies, Inc.
National Foundation for Cancer Research
Circle Internet Financial Ltd.
Allos Therapeutics, Inc.
American-Sino OB/GYN Hospital
IDG Technology Venture Investment, Inc.
CVie Therapeutics Co. Ltd.
IDG Capital Partners Co., Ltd.
Zenesis Ltd.
OMNI Pharmaceuticals (USA), Inc.
WUPIMA, Inc.
Smooth Prosper Ltd.
Creditease Holdings Cayman Ltd.
GenScript Corp.
MZ Investment Holdings Ltd.
KPCB China Fund II LP
IDG Technology Venture Investment III LLC
Crown Bioscience, Inc.
IDG Technology Venture Investments LP
Company contact information
CASI Pharmaceuticals, Inc.
9620 Medical Center Drive
Suite 300
Rockville, MD 20850

Phone : +1.240.864.2600
Fax : +1.240.315.2437
Web : www.casipharmaceuticals.com
© 2017 People , Fundamentals and Ownership